Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
† Indicates status has not been verified in more than two years